Ovoca Bio plc (AIM:OVB)

Ovoca Bio Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	0.66	1.15	5.42	6.1	2.21
Research & Development	-	0.42	-	-	-
Other Operating Expenses	-0.41	-1.02	-1.46	-0.24	-
Operating Expenses	0.25	0.85	3.97	5.86	2.21
Operating Income	-0.25	-0.85	-3.97	-5.86	-2.21
Interest Expense	-	-0.01	-0.04	-0.02	-0.02
Interest & Investment Income	-	-	0	0.1	0.23
Currency Exchange Gain (Loss)	0.25	0.05	-1.28	0.53	-0.33
EBT Excluding Unusual Items	-0	-0.81	-5.28	-5.25	-2.32
Gain (Loss) on Sale of Investments	-	-	-0.02	-	-
Gain (Loss) on Sale of Assets	-	-	-0.31	-	0
Asset Writedown	-	-4.3	-	-	-
Pretax Income	-0	-5.1	-5.61	-5.25	-2.32
Earnings From Continuing Operations	-0	-5.1	-5.61	-5.25	-2.32
Earnings From Discontinued Operations	-0.74	0.4	-	-0.23	-0.05
Net Income to Company	-0.75	-4.7	-5.61	-5.48	-2.37
Minority Interest in Earnings	-	-	-	-	0.04
Net Income	-0.75	-4.7	-5.61	-5.48	-2.34
Net Income to Common	-0.75	-4.7	-5.61	-5.48	-2.34
Shares Outstanding (Basic)	82	82	82	82	82
Shares Outstanding (Diluted)	82	82	82	82	82
EPS (Basic)	-0.01	-0.06	-0.07	-0.07	-0.03
EPS (Diluted)	-0.01	-0.06	-0.07	-0.07	-0.03
Free Cash Flow	-1.14	1.12	-5.16	-4.39	-2.12
Free Cash Flow Per Share	-0.01	0.01	-0.06	-0.05	-0.03
EBITDA	0.05	-0.55	-3.44	-5.78	-2.13
D&A For EBITDA	0.3	0.3	0.53	0.08	0.07
EBIT	-0.25	-0.85	-3.97	-5.86	-2.21

Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.